Background: The radiobiological mechanisms which may be exploited in t
he design of new strategies of radiochemotherapy are discussed. Method
s: The identification of exploitable mechanisms of radiochemotherapy h
as to be based on the analysis of cellular and supracellular mechanism
s of tumor cure, acute normal tissue injury and chronic normal tissue
injury, respectively, as well as on experimentally documented mechanis
ms of cellular and supracellular interactions of chemotherapy and radi
otherapy. Results: Only the addition of independent cytotoxic effects
of radiotherapy and of chemotherapy are a sound basis for predicting t
he therapeutic effects on tumor cure probability. In the pathogenesis
of normal tissue damage, however, complex interactions of supracellula
r mechanisms play a decisive role which may increase the rate of chron
ic side effects even in the absence of cellular interactions. Conclusi
on: None of the presently used schedules of radiochemotherapy meets th
e scientific requirements outlined in the paper. For squamous cell car
cinomas the most promising protocol would combine effective doses of c
hemotherapy and of radiotherapy without dose reduction and/or treatmen
t prolongation simultaneously but without causing increased normal tis
sue injury.